| Trident Lifeline Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 543616 |
NSE Symbol : - |
P/E(TTM) : 31.31 |
|
ISIN Demat : INE0MKA01014 |
Div & Yield% : - |
EPS(TTM) : 8.99 |
|
Book Value(₹) : 51.38 |
Market Cap(₹Cr) : 323.70 |
Face Value(₹) : 10.00 |
| Particulars | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
|---|---|---|---|---|---|---|
| Gross Sales | 15.66 | 14.74 | 18.99 | 7.09 | 9.93 | 8.64 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 15.66 | 14.74 | 18.99 | 7.09 | 9.93 | 8.64 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 0.52 | 0.47 | 1.26 | 0.23 | 0.38 | 0.33 |
| Total Income | 16.18 | 15.21 | 20.25 | 7.32 | 10.31 | 8.97 |
| Total Expenditure | 11.24 | 10.66 | 16.03 | 5.17 | 7.74 | 6.88 |
| PBIDT | 4.94 | 4.55 | 4.22 | 2.15 | 2.57 | 2.09 |
| Interest | 0.27 | 0.20 | 0.14 | 0.12 | 0.11 | 0.10 |
| PBDT | 4.67 | 4.35 | 4.08 | 2.03 | 2.47 | 1.99 |
| Depreciation | 0.16 | 0.33 | 0.19 | 0.28 | 0.16 | 0.13 |
| Tax | 1.12 | 1.01 | 1.07 | 0.25 | 0.60 | 0.46 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.00 | 0.00 | 0.37 | 0.00 | 0.00 | 0.00 |
| Reported Profit After Tax | 3.39 | 3.01 | 2.45 | 1.49 | 1.71 | 1.40 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 3.39 | 3.01 | 2.45 | 1.49 | 1.71 | 1.40 |
| EPS (Unit Curr.) | 2.95 | 2.62 | 2.13 | 1.29 | 2.13 | 1.22 |
| EPS (Adj) (Unit Curr.) | 2.95 | 2.62 | 2.13 | 1.29 | 2.13 | 1.22 |
| Calculated EPS (Unit Curr.) | 2.95 | 2.62 | 2.13 | 1.29 | 2.13 | 1.22 |
| Calculated EPS (Adj) (Unit Curr.) | 2.95 | 2.62 | 2.13 | 1.29 | 2.13 | 1.22 |
| Calculated EPS (Ann.) (Unit Curr.) | 11.80 | 10.48 | 8.51 | 5.18 | 8.53 | 4.88 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 11.80 | 10.48 | 8.51 | 5.18 | 8.53 | 4.88 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 11.50 | 11.50 | 11.50 | 11.50 | 8.00 | 11.50 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 31.55 | 30.87 | 22.22 | 30.32 | 25.88 | 24.19 |
| PBDTM(%) | 29.82 | 29.51 | 21.48 | 28.63 | 24.87 | 23.03 |
| PATM(%) | 21.65 | 20.42 | 12.90 | 21.02 | 17.22 | 16.20 |